These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8225657)
1. The effects of oral ibopamine in patients with mild heart failure--a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group. Parker JO Int J Cardiol; 1993 Jul; 40(3):221-7. PubMed ID: 8225657 [TBL] [Abstract][Full Text] [Related]
2. A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure. Andrews R; Charlesworth A; Evans A; Cowley AJ Eur Heart J; 1997 May; 18(5):852-7. PubMed ID: 9152656 [TBL] [Abstract][Full Text] [Related]
3. Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial. Wehling M; Zimmermann J; Theisen K Cardiology; 1990; 77 Suppl 5():81-8. PubMed ID: 2279257 [TBL] [Abstract][Full Text] [Related]
4. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Lok DJ; Dohmen HJ; Poortermans JC; Withagen AJ; Pasteuning WH; Brouwer J; Lie KI J Am Coll Cardiol; 1993 Nov; 22(6):1564-73. PubMed ID: 7901256 [TBL] [Abstract][Full Text] [Related]
5. Ibopamine in the treatment of mild chronic heart failure in elderly patients. A double-blind, placebo-controlled study. Azzolini A; Guffanti E; Ronzitti M; Tantalo L; Colantoni A; Pizzorni C Cardiology; 1990; 77 Suppl 5():89-95. PubMed ID: 2279258 [TBL] [Abstract][Full Text] [Related]
6. Ibopamine versus digoxin in the treatment of mild congestive heart failure. A double-blind, randomized, placebo-controlled trial. Kleber FX; Thyroff-Friesinger U Cardiology; 1990; 77 Suppl 5():75-80. PubMed ID: 2279256 [TBL] [Abstract][Full Text] [Related]
7. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group. Brouwer J; van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Boomsma F; Haaksma J; Lie KI J Am Coll Cardiol; 1995 Oct; 26(4):983-90. PubMed ID: 7560628 [TBL] [Abstract][Full Text] [Related]
8. Comparison of captopril and ibopamine in mild to moderate heart failure. Dohmen HJ; Dunselman PH; Poole-Wilson PA Heart; 1997 Sep; 78(3):285-90. PubMed ID: 9391292 [TBL] [Abstract][Full Text] [Related]
9. Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative study. Kleber FX; Thyroff-Friesinger U Cardiology; 1990; 77 Suppl 5():67-74. PubMed ID: 2279255 [TBL] [Abstract][Full Text] [Related]
10. Comparative effects of ibopamine and captopril in mild congestive heart failure. Focus on the long-term effects of inodilation on ventricular arrhythmias. Cocchieri M; Alunni GF; Del Favero A; Fortunati F; Bardelli G; Capponi EA; Regi L; Boschetti E Cardiology; 1990; 77 Suppl 5():36-42. PubMed ID: 2126222 [TBL] [Abstract][Full Text] [Related]
11. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study. G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585 [TBL] [Abstract][Full Text] [Related]
12. Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure. Szabó BM; van Veldhuisen DJ; van der Burgh PH; Kruik J; Girbes AR; Lie KI J Card Fail; 1996 Sep; 2(3):185-92. PubMed ID: 8891856 [TBL] [Abstract][Full Text] [Related]
13. Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure. SK & F Ibopamine Working Group. Cardiovasc Drugs Ther; 1989 Dec; 3(6):897-902. PubMed ID: 2487550 [TBL] [Abstract][Full Text] [Related]
14. [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure]. Wehling M; Zimmermann J; Weil J; Gerzer R; Theisen K Z Kardiol; 1990 Feb; 79(2):120-5. PubMed ID: 2157313 [TBL] [Abstract][Full Text] [Related]
15. The long-term efficacy of ibopamine in treating patients with severe heart failure: a multicenter investigation. Condorelli M; Bonaduce A; Montemurro A; Mattioli G; Cappello C; Caponnetto S; Terrachini V; Canale C; Varricchio M; Cacciapuoti F J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S83-92. PubMed ID: 2483445 [TBL] [Abstract][Full Text] [Related]
16. Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study. Alicandri C; Fariello R; Boni E; Zaninelli A; Muiesan G J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S77-82. PubMed ID: 2483444 [TBL] [Abstract][Full Text] [Related]
17. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial. Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446 [TBL] [Abstract][Full Text] [Related]
18. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial. van Veldhuisen DJ; Brouwer J; Man in 't Veld AJ; Dunselman PH; Boomsma F; Lie KI Am J Cardiol; 1995 Apr; 75(12):796-800. PubMed ID: 7717282 [TBL] [Abstract][Full Text] [Related]
19. Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure. Dei Cas L; Metra M; Visioli O Am J Cardiol; 1992 Sep; 70(6):629-34. PubMed ID: 1354938 [TBL] [Abstract][Full Text] [Related]
20. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study. Lewis BS; Rabinowitz B; Schlesinger Z; Caspi A; Markiewicz W; Rosenfeld T; Sclarovsky S; Ermer W Cardiology; 1999; 91(1):1-7. PubMed ID: 10393392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]